LSV Asset Management Sells 623,600 Shares of The Chemours Company (NYSE:CC)

LSV Asset Management decreased its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 33.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,248,400 shares of the specialty chemicals company's stock after selling 623,600 shares during the quarter. LSV Asset Management owned 0.84% of Chemours worth $21,098,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Corient Private Wealth LLC boosted its holdings in shares of Chemours by 4.7% in the 4th quarter. Corient Private Wealth LLC now owns 13,428 shares of the specialty chemicals company's stock worth $227,000 after purchasing an additional 604 shares in the last quarter. GAMMA Investing LLC boosted its stake in Chemours by 99.7% in the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock worth $26,000 after buying an additional 765 shares in the last quarter. HUB Investment Partners LLC grew its position in Chemours by 1.4% during the fourth quarter. HUB Investment Partners LLC now owns 58,250 shares of the specialty chemicals company's stock valued at $984,000 after acquiring an additional 821 shares during the last quarter. ARGA Investment Management LP grew its position in Chemours by 0.7% during the fourth quarter. ARGA Investment Management LP now owns 148,614 shares of the specialty chemicals company's stock valued at $2,512,000 after acquiring an additional 1,032 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its stake in shares of Chemours by 100.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock worth $38,000 after acquiring an additional 1,119 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Barclays reduced their target price on shares of Chemours from $19.00 to $16.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 1st. The Goldman Sachs Group decreased their price objective on Chemours from $24.00 to $21.00 and set a "neutral" rating on the stock in a report on Tuesday, January 7th. BMO Capital Markets dropped their target price on Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a report on Wednesday, February 19th. Truist Financial decreased their price target on Chemours from $27.00 to $22.00 and set a "buy" rating on the stock in a research note on Monday. Finally, Mizuho set a $15.00 target price on shares of Chemours in a research note on Tuesday. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $21.56.

Chemours Trading Down 3.4 %

NYSE CC traded down $0.40 during trading on Tuesday, hitting $11.13. The company had a trading volume of 1,744,948 shares, compared to its average volume of 1,825,919. The Chemours Company has a one year low of $9.33 and a one year high of $29.21. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The company's fifty day moving average is $14.25 and its 200-day moving average is $17.49. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 19.52 and a beta of 1.84.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. On average, sell-side analysts predict that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 8.99%. The ex-dividend date was Friday, February 28th. Chemours's payout ratio is currently 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.